Monoclonal antibodies in tumor therapy: present stage, chances and limitations
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Basel ; München [u.a.]
Karger
1988
|
| Schriftenreihe: | Beiträge zur Onkologie
32 |
| Schlagworte: | |
| Beschreibung: | Literaturverz. S. [133] - 178 |
| Beschreibung: | VII, 178 S. Ill., graph. Darst. |
| ISBN: | 3805547633 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV000753681 | ||
| 003 | DE-604 | ||
| 005 | 20130624 | ||
| 007 | t | ||
| 008 | 880531s1988 ad|| |||| 00||| eng d | ||
| 020 | |a 3805547633 |9 3-8055-4763-3 | ||
| 035 | |a (OCoLC)18686331 | ||
| 035 | |a (DE-599)BVBBV000753681 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-19 |a DE-355 |a DE-29 |a DE-20 |a DE-188 |a DE-578 | ||
| 050 | 0 | |a RC271.M65 | |
| 084 | |a XH 1500 |0 (DE-625)152870:12905 |2 rvk | ||
| 084 | |a XH 3200 |0 (DE-625)152888:12905 |2 rvk | ||
| 245 | 1 | 0 | |a Monoclonal antibodies in tumor therapy |b present stage, chances and limitations |c H. H. Sedlacek ... |
| 264 | 1 | |a Basel ; München [u.a.] |b Karger |c 1988 | |
| 300 | |a VII, 178 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Beiträge zur Onkologie |v 32 | |
| 500 | |a Literaturverz. S. [133] - 178 | ||
| 650 | 4 | |a Antibodies, Monoclonal |x therapeutic use | |
| 650 | 4 | |a Monoclonal antibodies |x Therapeutic use | |
| 650 | 4 | |a Neoplasms |x drug therapy | |
| 650 | 4 | |a Tumors |x Chemotherapy | |
| 650 | 4 | |a Tumors |x Immunotherapy | |
| 650 | 0 | 7 | |a Therapie |0 (DE-588)4059798-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Tumor |0 (DE-588)4078460-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Monoklonaler Antikörper |0 (DE-588)4040094-3 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 655 | 7 | |a Monoklonare Antikörper |2 gnd |9 rswk-swf | |
| 689 | 0 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 0 | 1 | |a Monoklonaler Antikörper |0 (DE-588)4040094-3 |D s |
| 689 | 0 | 2 | |a Therapie |0 (DE-588)4059798-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Tumor |0 (DE-588)4078460-5 |D s |
| 689 | 1 | 1 | |a Therapie |0 (DE-588)4059798-2 |D s |
| 689 | 1 | 2 | |a Monoklonare Antikörper |A f |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Sedlacek, Hans-Harald |d 1943- |e Sonstige |0 (DE-588)1029511926 |4 oth | |
| 830 | 0 | |a Beiträge zur Onkologie |v 32 |w (DE-604)BV000000016 |9 32 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-000471703 | ||
Datensatz im Suchindex
| _version_ | 1804115205892866048 |
|---|---|
| any_adam_object | |
| author_GND | (DE-588)1029511926 |
| building | Verbundindex |
| bvnumber | BV000753681 |
| callnumber-first | R - Medicine |
| callnumber-label | RC271 |
| callnumber-raw | RC271.M65 |
| callnumber-search | RC271.M65 |
| callnumber-sort | RC 3271 M65 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | XH 1500 XH 3200 |
| ctrlnum | (OCoLC)18686331 (DE-599)BVBBV000753681 |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02072nam a2200553 cb4500</leader><controlfield tag="001">BV000753681</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20130624 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">880531s1988 ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3805547633</subfield><subfield code="9">3-8055-4763-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)18686331</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV000753681</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-188</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC271.M65</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 1500</subfield><subfield code="0">(DE-625)152870:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 3200</subfield><subfield code="0">(DE-625)152888:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Monoclonal antibodies in tumor therapy</subfield><subfield code="b">present stage, chances and limitations</subfield><subfield code="c">H. H. Sedlacek ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel ; München [u.a.]</subfield><subfield code="b">Karger</subfield><subfield code="c">1988</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VII, 178 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Beiträge zur Onkologie</subfield><subfield code="v">32</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturverz. S. [133] - 178</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antibodies, Monoclonal</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Monoclonal antibodies</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tumors</subfield><subfield code="x">Chemotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tumors</subfield><subfield code="x">Immunotherapy</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Tumor</subfield><subfield code="0">(DE-588)4078460-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Monoklonaler Antikörper</subfield><subfield code="0">(DE-588)4040094-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Monoklonare Antikörper</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Monoklonaler Antikörper</subfield><subfield code="0">(DE-588)4040094-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Tumor</subfield><subfield code="0">(DE-588)4078460-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Monoklonare Antikörper</subfield><subfield code="A">f</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sedlacek, Hans-Harald</subfield><subfield code="d">1943-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)1029511926</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Beiträge zur Onkologie</subfield><subfield code="v">32</subfield><subfield code="w">(DE-604)BV000000016</subfield><subfield code="9">32</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-000471703</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content Monoklonare Antikörper gnd |
| genre_facet | Aufsatzsammlung Monoklonare Antikörper |
| id | DE-604.BV000753681 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T15:18:55Z |
| institution | BVB |
| isbn | 3805547633 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-000471703 |
| oclc_num | 18686331 |
| open_access_boolean | |
| owner | DE-12 DE-19 DE-BY-UBM DE-355 DE-BY-UBR DE-29 DE-20 DE-188 DE-578 |
| owner_facet | DE-12 DE-19 DE-BY-UBM DE-355 DE-BY-UBR DE-29 DE-20 DE-188 DE-578 |
| physical | VII, 178 S. Ill., graph. Darst. |
| publishDate | 1988 |
| publishDateSearch | 1988 |
| publishDateSort | 1988 |
| publisher | Karger |
| record_format | marc |
| series | Beiträge zur Onkologie |
| series2 | Beiträge zur Onkologie |
| spelling | Monoclonal antibodies in tumor therapy present stage, chances and limitations H. H. Sedlacek ... Basel ; München [u.a.] Karger 1988 VII, 178 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Beiträge zur Onkologie 32 Literaturverz. S. [133] - 178 Antibodies, Monoclonal therapeutic use Monoclonal antibodies Therapeutic use Neoplasms drug therapy Tumors Chemotherapy Tumors Immunotherapy Therapie (DE-588)4059798-2 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Tumor (DE-588)4078460-5 gnd rswk-swf Monoklonaler Antikörper (DE-588)4040094-3 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Monoklonare Antikörper gnd rswk-swf Krebs Medizin (DE-588)4073781-0 s Monoklonaler Antikörper (DE-588)4040094-3 s Therapie (DE-588)4059798-2 s DE-604 Tumor (DE-588)4078460-5 s Monoklonare Antikörper f Sedlacek, Hans-Harald 1943- Sonstige (DE-588)1029511926 oth Beiträge zur Onkologie 32 (DE-604)BV000000016 32 |
| spellingShingle | Monoclonal antibodies in tumor therapy present stage, chances and limitations Beiträge zur Onkologie Antibodies, Monoclonal therapeutic use Monoclonal antibodies Therapeutic use Neoplasms drug therapy Tumors Chemotherapy Tumors Immunotherapy Therapie (DE-588)4059798-2 gnd Krebs Medizin (DE-588)4073781-0 gnd Tumor (DE-588)4078460-5 gnd Monoklonaler Antikörper (DE-588)4040094-3 gnd |
| subject_GND | (DE-588)4059798-2 (DE-588)4073781-0 (DE-588)4078460-5 (DE-588)4040094-3 (DE-588)4143413-4 |
| title | Monoclonal antibodies in tumor therapy present stage, chances and limitations |
| title_auth | Monoclonal antibodies in tumor therapy present stage, chances and limitations |
| title_exact_search | Monoclonal antibodies in tumor therapy present stage, chances and limitations |
| title_full | Monoclonal antibodies in tumor therapy present stage, chances and limitations H. H. Sedlacek ... |
| title_fullStr | Monoclonal antibodies in tumor therapy present stage, chances and limitations H. H. Sedlacek ... |
| title_full_unstemmed | Monoclonal antibodies in tumor therapy present stage, chances and limitations H. H. Sedlacek ... |
| title_short | Monoclonal antibodies in tumor therapy |
| title_sort | monoclonal antibodies in tumor therapy present stage chances and limitations |
| title_sub | present stage, chances and limitations |
| topic | Antibodies, Monoclonal therapeutic use Monoclonal antibodies Therapeutic use Neoplasms drug therapy Tumors Chemotherapy Tumors Immunotherapy Therapie (DE-588)4059798-2 gnd Krebs Medizin (DE-588)4073781-0 gnd Tumor (DE-588)4078460-5 gnd Monoklonaler Antikörper (DE-588)4040094-3 gnd |
| topic_facet | Antibodies, Monoclonal therapeutic use Monoclonal antibodies Therapeutic use Neoplasms drug therapy Tumors Chemotherapy Tumors Immunotherapy Therapie Krebs Medizin Tumor Monoklonaler Antikörper Aufsatzsammlung Monoklonare Antikörper |
| volume_link | (DE-604)BV000000016 |
| work_keys_str_mv | AT sedlacekhansharald monoclonalantibodiesintumortherapypresentstagechancesandlimitations |